Literature DB >> 25278264

Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation.

A Tena1, J Kurtz, D A Leonard, J R Dobrinsky, S L Terlouw, N Mtango, J Verstegen, S Germana, C Mallard, J S Arn, D H Sachs, R J Hawley.   

Abstract

Mixed chimerism approaches for induction of tolerance of solid organ transplants have been applied successfully in animal models and in the clinic. However, in xenogeneic models (pig-to-primate), host macrophages participate in the rapid clearance of porcine hematopoietic progenitor cells, hindering the ability to achieve mixed chimerism. CD47 is a cell-surface molecule that interacts in a species-specific manner with SIRPα receptors on macrophages to inhibit phagocytosis and expression of human CD47 (hCD47) on porcine cells has been shown to inhibit phagocytosis by primate macrophages. We report here the generation of hCD47 transgenic GalT-KO miniature swine that express hCD47 in all blood cell lineages. The effect of hCD47 expression on xenogeneic hematopoietic engraftment was tested in an in vivo mouse model of human hematopoietic cell engraftment. High-level porcine chimerism was observed in the bone marrow of hCD47 progenitor cell recipients and smaller but readily measurable chimerism levels were observed in the peripheral blood of these recipients. In contrast, transplantation of WT progenitor cells resulted in little or no bone marrow engraftment and no detectable peripheral chimerism. These results demonstrate a substantial protective effect of hCD47 expression on engraftment and persistence of porcine cells in this model, presumably by modulation of macrophage phagocytosis. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Animal models: nonhuman primate; animal models: porcine; basic (laboratory) research/science; immunosuppression/immune modulation; tolerance: chimerism; xenotransplantation

Mesh:

Substances:

Year:  2014        PMID: 25278264      PMCID: PMC4236244          DOI: 10.1111/ajt.12918

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  49 in total

1.  Interactions between CD47 and thrombospondin reduce inflammation.

Authors:  Laurence Lamy; Arnaud Foussat; Eric J Brown; Paul Bornstein; Michel Ticchioni; Alain Bernard
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

2.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

3.  Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.

Authors:  M L Blakely; W J Van der Werf; M C Berndt; A P Dalmasso; F H Bach; W W Hancock
Journal:  Transplantation       Date:  1994-11-27       Impact factor: 4.939

4.  Polymorphic Sirpa is the genetic determinant for NOD-based mouse lines to achieve efficient human cell engraftment.

Authors:  Takuji Yamauchi; Katsuto Takenaka; Shingo Urata; Takahiro Shima; Yoshikane Kikushige; Takahito Tokuyama; Chika Iwamoto; Mariko Nishihara; Hiromi Iwasaki; Toshihiro Miyamoto; Nakayuki Honma; Miki Nakao; Takashi Matozaki; Koichi Akashi
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

5.  Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning.

Authors:  Liangxue Lai; Donna Kolber-Simonds; Kwang-Wook Park; Hee-Tae Cheong; Julia L Greenstein; Gi-Sun Im; Melissa Samuel; Aaron Bonk; August Rieke; Billy N Day; Clifton N Murphy; David B Carter; Robert J Hawley; Randall S Prather
Journal:  Science       Date:  2002-01-03       Impact factor: 47.728

6.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

Authors:  T Kawai; A Poncelet; D H Sachs; S Mauiyyedi; S Boskovic; S L Wee; D S Ko; A Bartholomew; M Kimikawa; H Z Hong; G Abrahamian; R B Colvin; A B Cosimi
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

7.  Transcriptional reprogramming of gene expression in bovine somatic cell chromatin transfer embryos.

Authors:  Nelida Rodriguez-Osorio; Zhongde Wang; Poothappillai Kasinathan; Grier P Page; James M Robl; Erdogan Memili
Journal:  BMC Genomics       Date:  2009-04-24       Impact factor: 3.969

8.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

9.  Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.

Authors:  Christin M Lepus; Thomas F Gibson; Scott A Gerber; Ivana Kawikova; Marian Szczepanik; Jaber Hossain; Vitaly Ablamunits; Nancy Kirkiles-Smith; Kevan C Herold; Ruben O Donis; Alfred L Bothwell; Jordan S Pober; Martha J Harding
Journal:  Hum Immunol       Date:  2009-06-12       Impact factor: 2.850

10.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
View more
  21 in total

Review 1.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

Review 2.  Advances in the immunology of heart transplantation.

Authors:  Joren C Madsen
Journal:  J Heart Lung Transplant       Date:  2017-10-20       Impact factor: 10.247

Review 3.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

4.  Early barriers to neonatal porcine islet engraftment in a dual transplant model.

Authors:  K P Samy; R P Davis; Q Gao; B M Martin; M Song; J Cano; A B Farris; A McDonald; E K Gall; C R Dove; F V Leopardi; T How; K D Williams; G R Devi; B H Collins; A D Kirk
Journal:  Am J Transplant       Date:  2017-12-28       Impact factor: 8.086

5.  Donor SIRPα polymorphism modulates the innate immune response to allogeneic grafts.

Authors:  Hehua Dai; Andrew J Friday; Khodor I Abou-Daya; Amanda L Williams; Steven Mortin-Toth; Matthew L Nicotra; David M Rothstein; Warren D Shlomchik; Takashi Matozaki; Jeffrey S Isenberg; Martin H Oberbarnscheidt; Jayne S Danska; Fadi G Lakkis
Journal:  Sci Immunol       Date:  2017-06-23

Review 6.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

Review 7.  The role of genetically engineered pigs in xenotransplantation research.

Authors:  David K C Cooper; Burcin Ekser; Jagdeece Ramsoondar; Carol Phelps; David Ayares
Journal:  J Pathol       Date:  2015-10-07       Impact factor: 7.996

Review 8.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

Review 9.  Skin xenotransplantation: Historical review and clinical potential.

Authors:  Takayuki Yamamoto; Hayato Iwase; Timothy W King; Hidetaka Hara; David K C Cooper
Journal:  Burns       Date:  2018-03-27       Impact factor: 2.744

Review 10.  Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation.

Authors:  David K C Cooper; Mohamed Ezzelarab; Hayato Iwase; Hidetaka Hara
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.